An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

P Bedossa1, T Poynard

  • 1Service d'Anatomie Pathologique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.

Insights

A new, simple algorithm accurately grades chronic hepatitis C activity using basic pathological features like piecemeal and lobular necrosis. This method shows substantial concordance, matching statistical approaches for reliable histological assessment.

Area of Science:

  • Hepatology
  • Pathology
  • Medical Diagnostics

Background:

  • Histological activity assessment is crucial for managing chronic hepatitis C.
  • Current grading relies on subjective evaluation of necroinflammatory lesions.
  • A standardized, objective scoring system is needed.

Purpose of the Study:

  • To develop and validate a simple algorithm for grading histological activity in chronic hepatitis C.
  • To compare the algorithm's accuracy with expert pathologist consensus and statistical modeling.
  • To identify key pathological features influencing activity grading.

Main Methods:

  • A panel of 10 pathologists reviewed 363 chronic hepatitis C liver biopsies.
  • An expert consensus algorithm was developed for activity grading.
  • Stepwise discriminant analysis identified features used in expert grading.
  • Concordance analysis (kappa statistic) assessed algorithm accuracy against reference and statistical activity scores.

Main Results:

  • The expert consensus algorithm, incorporating piecemeal and lobular necrosis, achieved substantial concordance (84%, kappa = .75) with reference activity.
  • Discriminant analysis revealed piecemeal necrosis, lobular necrosis, and portal inflammation as key features.
  • The algorithm's accuracy was comparable to a statistical model (83%, kappa = .73).

Conclusions:

  • A simple, consensus-based algorithm provides an accurate method for grading histological activity in chronic hepatitis C.
  • The algorithm's performance is on par with more complex statistical approaches.
  • This tool can aid in standardized and reliable assessment of liver disease activity.